| Literature DB >> 23251650 |
Deepika Jaiswal1, Sameer Trivedi, Rajendra Singh, Rima Dada, Kiran Singh.
Abstract
Interleukin-1 (IL-1) is a regulatory cytokine that plays an important role in the maintenance of the immune environment of the testis, regulation of junction dynamics and cell differentiation during spermatogenesis. Members of the IL-1 family are pleiotropic cytokines that are involved in inflammation, immunoregulation and other homeostatic functions in the body. IL-1α, IL-1β, and the IL-1 receptor antagonistic molecule (IL-1 Ra) are expressed in the testis under normal homeostasis and they further increase upon infection/inflammation. In the present study we have examined the association of Variable Number Tandem Repeats (VNTR) polymorphism of the Interleukin-1 receptor antagonist gene (IL1RN) with human male infertility. The case-control study comprised of two groups: 331 idiopathic infertile patients and 358 fertile healthy men. The study indicates risk of IL1RN2 variant with male infertility (OR: 1.43, CI: 1.1546 to 1.7804, P = 0.001). To our best knowledge, this is the first report that links IL1RN VNTR polymorphism with human male infertility.Entities:
Mesh:
Substances:
Year: 2012 PMID: 23251650 PMCID: PMC3522614 DOI: 10.1371/journal.pone.0051899
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1PCR amplified products of IL1RN genes VNTR polymorphism. A. Lane 1
∶50 bp DNA ladder; Lane 2: IL1RN1/IL1RN1; Lane 3: IL1RN1/IL1RN4, Lane 4: IL1RN2/IL1RN2 , Lane5: IL1RN4/IL1RN2. B. Lane 1: puc/hinf1 DNA ladder; Lane 2: IL1RN1/IL1RN1 , Lane 3: IL1RN2/IL1RN3 , Lane 4: IL1RN1/IL1RN1 , Lane5: IL1RN1/IL1RN2, Lane 6: IL1RN1/IL1RN6 , Lane 7: IL1RN2/IL1RN2.
Figure 2Schematic diagram of the IL1RN gene showing the position of the VNTR polymorphism along with various alleles.
Distribution of VNTR of IL1RN genotypes and alleles among infertile patients and fertile controls.
| Genotypes | Controls | Azoospermia(1) | Severe Oligozoospermia/ oligozoospermia | Asthenozoospermia | Total | Odds Ratio (95% CI)# | p-Value | Yates’ Corrected p-Value | |||||||||
| (n = 358) | (n = 168 ) | (2) (n = 42 ) | (3) (n = 121) | (1+2+3) (n = 331) | (1) | (2) | (3) | Total (1+2+3) | (1) | (2) | (3) | Total (1+2+3) | (1) | (2) | (3) | Total (1+2+3) | |
| IL1RN1/1 | 155 (43.29%) | 55 (32.73%) | 16 (38.09%) | 37 (30.58%) | 108 (32.63%) | Reference | – | ||||||||||
| IL1RN2/2 | 60 (16.76%) | 38 (22.61%) | 9 (21.43%) | 33 (27.27%) | 80 (24.17%) | 1.8 (1.0765 to 3.0544) | 1.5 (0.5947 to 3.6936) | 2.4 (1.3468 to 4.2469) | 1.9 (1.2635 to 2.8718) | 0.02 | 0.39 | 0.002 | 0.002 | 0.03 | 0.42 | 0.004 | 0.003 |
| IL1RN1/2 | 139 (38.83%) | 69 (41.07%) | 13 (30.95%) | 49 (40.49%) | 131 (39.58%) | 1.4 (0.9182 to 2.1236) | 0.9 (0.4226 to 1.9446) | 1.5 (0.9112 to 2.3795) | 1.4 (0.9605 to 1.9001) | 0.11 | 0.80 | 0.11 | 0.08 | 0.14 | 0.95 | 0.14 | 0.1 |
| Rare | 4 (1.12%) | 6 (3.57%) | 4 (9.52%) | 2 (1.65%) | 12 (3.62%) | 5.4 (1.3042 to 22.0525) | 2.4 (0.3156 to 18.5884) | 3.9 (1.4361 to 10.9908) | 0.01 | 0.003 | 0.39 | 0.007 | 0.04 | 0.003 | 0.74 | 0.01 | |
| IL1RN alleles | |||||||||||||||||
| IL1RN1 | 452 (63.13%) | 183 (54.46%) | 48 (57.14%) | 125 (51.65%) | 356 (53.77%) | Reference | – | ||||||||||
| IL1RN2 | 260 (36.31%) | 147 (43.75%) | 32 (38.09%) | 115 (47.52%) | 294 (44.41%) | 1.4 (1.072 to 1.8301) | 1.2 (0.7194 to 1.8742) | 1.6 (1.1945 to 2.1733) | 1.4 (1.1546 to 1.7804) | 0.01 | 0.54 | 0.001 | 0.001 | 0.02 | 0.62 | 0.002 | 0.001 |
| Rare | 4 (0.56%) | 6 (1.78%) | 4 (4.76%) | 2 (0.83%) | 12 (1.81%) | 4.5 (1.1405 to 17.7115) | - | 1.9 (0.2828 to 13.882) | 3.5 (1.2952 to 9.473) | 0.03 | 0.0001 | 0.49 | 0.01 | 0.07 | 0.001 | 0.84 | 0.03 |
Note: OR = odds Ratio; CI = 95% confidence interval.
Significant p-value;
Controls vs. (1), (2), (3), (1+2+3).
Rare genotypes contain alleles 3, 4, or 6.
There is no simple link between the number of repeats and the number of the allele.